Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. Nephro-Urology Monthly
  4. Articles

  5. Expression of Programmed Death-1 Ligand in Renal Cell Carcinoma and Its Relationship with Pathologic Findings and Disease-Free Survival
  6. Scopus by Title (Ref)

Nephro-Urology Monthly

homeHome
play_arrowCurrent IssuelistAll Issuesformat_indent_increaseIn PresssearchSearchcheck_circleAccepted Manuscripts
settingsInstructions
bookmarkJournal InformationgroupsBoards and CommitteesshareIndexing and Listing SourcesbalancePublication Ethics and Malpractice StatementemailSupportassignment_indReviewer and AE Registration FormphoneContact Usshow_chartJournal Metricszoom_inOpen Peer Review (OPR)
format_list_bulletedAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Refining Prognostic Stratification in Clear Cell Renal Cell Carcinoma: Genomic, Tissue-Based, Circulating Biomarkers and Integrated Models

- Chifu M.B. , et al.

2. Evaluation of the Expression of Immunohistochemical Staining of PDL1 in Renal Cell Cancer

- Al-Nuaimy R.M.E. , et al.

3. The Role of PDL1 Immunostain Expression in RCC: A Clinicopathological Study

- Al-Nuaimy R.M.E. , et al.

4. Correlation between PD-L1 and Ki-67 Expression at various T-stage Clear Cell Renal Cell Carcinomas

- Rahaju A.S. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press
  • Search
  • Accepted Manuscripts

About Journal

  • Journal Information
  • Boards and Committees
  • Indexing and Listing Sources
  • Publication Ethics and Malpractice Statement
  • Support
  • Reviewer and AE Registration Form
  • Contact Us
  • Journal Metrics
  • Open Peer Review (OPR)
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.